Pharmacological effects of fonturacetam (Actitropil) and prospects for its clinical use

Close metadata

Recommended articles:

Cognitive impairment in patients with arterial hypertension. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):41-48

Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18

Modern aspects of chronic cerebral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113

Neurocytoprotection advances in reperfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88

Efficacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79

Possibilities of physiotherapy in glaucomatous optic neuropathy after glaucoma surgery. Russian Annals of Ophthalmology. 2024;(3):88-94

Neuroprotective therapy for age-related macular degeneration. Russian Annals of Ophthalmology. 2024;(6):152-158

Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90

Phenylpiracetam (PP) is a nootropic drug with additional pharmacological effects, including anxiolytic, antiasthenic, antidepressant, anti-inflammatory and anticonvulsant effects. The paper presents the results of an analysis of experimental and clinical studies, which indicate the prospects for the use of PP in cerebral ischemia, neurodegenerative pathologies, epilepsy, asthenia, and mental disorders. The adaptogenic properties and mitochondrial protective effect of PP are considered, assessments of the possible effect of PP on neurotransmitter systems, regulation of carbohydrate and fat metabolism with the prospects for the use of PP in patients with metabolic syndrome.

Keywords:

nootropics

neuroprotection

racetams

phenylpiracetam

Authors:

Gromova O.A.

Federal Research Center «Computer Science and Control»

ORCID: 0000-0002-7663-710X

Torshin I.Yu.

Federal Research Center «Computer Science and Control»

ORCID: 0000-0002-2659-7998

Received:

14.05.2024

Accepted:

24.05.2024

List of references:

https://www.garant.ru/products/ipo/prime/doc/72761778/ https://www.garant.ru/products/ipo/prime/doc/72761778/
Badalyan OL, Savenkov AA, Avakyan GN, Yutskova EV. Possibilities of using nootropic drugs in complex treatment of epilepsy. Epilepsy and paroxysmal conditions. 2013;5(2):24-30. (In Russ.).
GOST 12.1.007-76 «Harmful substances. Classification and general safety requirements. (In Russ.). https://ecomonitoring360.ru/gost-12-1-007-76/]
Antonova MI. Experimental pharmacokinetics of phenotropil. Diss. … can of chem. Sci. Moscow, 2005. (In Russ.).
Antonova MI, Prokopov AA, Akhapkina VI, Berlyand AS. Experimental pharmacokinetics of phenotropil in rats. Chemical-Pharmaceutical Journal. 2003;37(11):7-8. (In Russ.).
Kovalev GI, Akhapkina VI, Abaimov DA, Firstova YuYu. Phenotropil as a receptor modulator of synaptic neuropransmission. Nervous Diseases. 2007;4:22-26. (In Russ.).
Osipchuk DO, Driker MB. Influence of the neuromodulator phenotropil, administrated prenatally, on the behavioral activity of animals in the postnatal period of development. Bulletin of the Ural Medical Academic Science. 2010;1(28):66-69. (In Russ.).
Khamidova TV, Chigirinsky YuL. Influence of carphedon on the reproductive function of female rats. Experimental and Clinical Pharmacology. 2005; 68(5):29-31. (In Russ.).
Chebotareva LL, Muravsky AV, Solonovich AS. The effectiveness of the drug Entrop in the treatment of asthenia in patients who have suffered traumatic brain injury. International Journal of Neurology. 2016;7:85-90. (In Russ.).
Gorodnik GA, Andronova IA, Andronova MA, et al. Correction of glutamate excitotoxicity in patients with severe traumatic brain injury. Vestnic Donetsk State Medical University M. Gorky. 2017;1(3):48-52. (In Russ.).
Putilina MV. Effective neuromodulation as the basis of modern neuroprotection in the therapy of vascular diseases of the nervous system. Nervous Diseases. 2022;1:72-76. (In Russ.).
Torshin IY. The study of the solvability of the genome annotation problem on sets of elementary motifs. Advances in Mathematical Theory and Applications. 2011;21(4):652-662.
Rudakov KV, Torshin IYu. On the selection of informative feature values based on solvability criteria in the problem of protein secondary structure recognition. Reports of the Academy of Sciences. 2011;441(1):24-28. (In Russ.).
Bogolepova AN. Therapy of emotional and cognitive disorders in patients with chronic brain ischemia. Pharmateka. 2014;9:59-64. (In Russ.).
Perfilova VN, Borodkina LE. Participation of the gamma-aminoylanoyanocyoki-ergic system in the regulation of cerebral circulation. Bulletin of the Russian Military Medical Academy. 2014;1(45):203-211. (In Russ.).
Kurkin DV, Voskresensky SA, Bagmetov MN, Epishina VV. Neuroprotectory properties of phenotropil and its new derivatives in conditions of gravitational ischemia. In the book: X Regional Conference of Young Researchers of the Volgograd Region. Abstracts of reports. Ed. by M.E. Statsenko. 2005;28-29. (In Russ.).
Tyurenkov IN, Bagmetov MN, Epishina VV. Phenotropil and piracetam — comparative characteristics of neuroprotectory effects under conditions of experimental cerebral ischemia in laboratory animals. In the collection: Phenotropil. Experimental clinical pharmacology and practical application. Digest of articles. Moscow, 2007;27-33. (In Russ.).
Kovalchuk VV, Kovalchuk IV, Vysotskaya ML, et al. The effect of phenotropil on the functional state and quality of life of patients after stroke. The Practitioner. 2013;1:33-36. (In Russ.).
Tchaikovsky YuN, Elchaninov AP. Phenotropil in the system of drug rehabilitation of patients with hemiparesis after ischemic stroke. Nervous Diseases. 2007;1:35-39. (In Russ.).
Savchenko AIu, Zakharova NS, Stepanov IN. The phenotropil treatment of the consequences of brain organic lesions. S.S. Korsakov Journal of Neurology and Psychiatry. 2005;105(12):22-26. (In Russ.).
Fedin AI, Solovyova EYu, Mironova OP, Fedotova AV. Treatment of asthenic syndrome in patients with chronic cerebral ischemia: results of the non-interventional observation program «TRIUMPH». Pharmacy of Kazakhstan. 2015;5(168):46-55. (In Russ.).
Lemeshko EKh, Kolesnichenko LS, Verlan NV, et al. Study of the glutathione system in patients with chronic cerebral ischemia and type 2 diabetes mellitus during treatment with phenotropil. Biomedicine. 2010;3:87-88. (In Russ.).
Selyanina NV, Shutov AA. Experience of using phenotropil in patients with initial manifestations of insufficiency of blood supply to the brain. Nervous Diseases. 2005;4:30-32. (In Russ.).
Fedin AI, Amcheslavskaya EV, Krasnoperov EN, et al. Use of phenotropil in patients with chronic brain ischemia and moderate cognitive impairments. Nervous Diseases. 2010;3:22-31. (In Russ.).
Vasiliev YuN, Kolesnikova OA. Influence of the drug fenotropil on motor functions of patients with Parkinson’s disease. Basic research. 2008;12:74-78. (In Russ.).
Karabanov AV, Shvedkov VV, Illarioshkin SN. Experience of using phenotropil in parkinson’s disease. Nervous Diseases. 2009;4:29-32. (In Russ.).
Zhukova NG, Masenko AYa, Kuznetsova KS, et al. Neurometabolic therapy for Parkinson’s disease. Attending Doctor. 2023;26(6):62-68. (In Russ.).
Sazonov DV, Ryabukhina OV, Bulatova EV, et al. Experience of using phenotropil in complex treatment of multiple sclerosis. Nervous Diseases. 2006; 4:18-21. (In Russ.).
Bogatyreva IA. Improving treatment and preventive measures for patients with occupational polyneuropathies and disorders of the body’s adaptive systems. Materials of the XIII All-Russian scientific and practical conference with international participation. In 2 volumes. Edited by A.Yu. Popova, N.V. Zaitseva. Perm, 2023;308-313. (In Russ.).
Bobkov IuG, Morozov IS, Glozman OM, et al. Pharmacological characteristics of a new phenyl analog of piracetam-4-phenylpiracetam. Biull Eksp Biol Med. 1983 Apr;95(4):50-3.
Borodkina LE, Kovtun VV, Berestovitskaya VM, et al. Anticonvatvant effect of carphedon derivatives. In the collection: Proceedings of the 56th regional conference on pharmacy, pharmacology and personnel training. Collection of scientific papers. Pyatigorsk State Pharmaceutical Academy. 2001;175. (In Russ.).
Starodubtsev AV, Sarapeev ChN, Zhalsanov YuV, et al. Differentiated use of phenotropil in progradent course of focal forms of epilepsy. Siberian Medical Journal (Irkutsk). 2009;90(7):49-51. (In Russ.).
Grebenyuk OV, Zhukova NG, Alifirova VM. Effectiveness of additional therapy with phenotropil for locally-caused epilepsy in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(11-2):27-31. (In Russ.).
Savenkov AA, Badalian OL, Avakian GN. Nootropics and antioxidants in the complex therapy of symptomatic posttraumatic epilepsy. S.S. Korsakov Zhurnal of Nevrology and Psikhiatry. 2013;113(6):26-34. (In Russ.).
Belskaya GN, Ponomareva IA. New opportunities for increasing the performance of complex therapy for symptomatic locally-caused epilepsy with a resistant course. Ural Medical Journal. 2011;10(88):63-67. (In Russ.).
Khasanova DR, Zhitkova YuV, Vaskaeva GR. Post-Covid syndrome: a review of knowledge about pathogenesis, neuropsychiatric manifestations and treatment prospects. Neurology, neuropsychiatry, psychosomatics. 2021;13(3):93-98. (In Russ.).
Okhremchuk LV, Seminsky IZh. Features of behavior of mogular rats during acute intoxication with aminazine and its correction with phenotropil. Siberian Medical Journal. 2010;95(4):57-59. (In Russ.).
Devlikamova FI. Effectiveness and safety of actitropil in patients with asthenic syndrome. Nervous Diseases. 2022;4:36-46. (In Russ.).
Yuryeva LN, Dukelsky AA, Shusterman TI, et al. Assessment of the effectiveness of phenylpiracetam (entrop) in the treatment of patients with asthenia of organic and neurotic genesis. Psychiatry, Psychotherapy and Clinical Psychology. 2019;10(1):135-147. (In Russ.).
Golubovskaya OA, Gudzenko OA, Shestakova IV, et al. Post-infectious asthenic syndrome and possibilities for its correction. Clinical Infectology and Parasitology. 2018;7(1):140-148. (In Russ.).
Priluchny SV, Samotrueva MA, Tyurenkov IN, et al. Influence of phenotropil and phenibut on the behavior of animals under conditions of experimental hyperthyroidsis. Modern High Technology. 2010;9:138-141. (In Russ.).
Visilo TL. Efficacy and safety of the drug Actitropil in the treatment of reactive asthenia in young patients. Farmateka. 2023;9:159-166. (In Russ.). https://doi.org/10.18565/pharmateca.2023.9-10.159-166
Tokareva ER, Loginova NB. Possibilities of neuroprotective therapy with Actitropil (phenylpiracetam) in patients in the post-Covid period with comorbid neurological pathology. Nervous Diseases. 2023;3:62-68. (In Russ.). https://doi.org/10.24412/2226-0757-2023-13008
Saley AP, Meshcheryakova MYu. Influence of phenotropil on conditioned reflex behavior. In the collection: Medical, biological and pedagogical foundations of adaptation, sports activity and a healthy lifestyle. collection of scientific articles of the V All-Russian correspondence scientific and practical conference with international participation. Voronezh State Institute of Physical Culture. 2016;73-75. (In Russ.).
Zvejniece L, Svalbe B, Veinberg G, et al. Investigation into stereoselective pharmacological activity of phenotropil. Basic Clin Pharmacol Toxicol. 2011; 109(5):407-412. https://doi.org/10.1111/j.1742-7843.2011.00742.x
Zinchuk AN, Zubach EA, Orfin AYa, Plevachuk OYu. Asthenic syndrome and its correction in patients with infectious pathology. Family Medicine. 2019;4(84):41-46. (In Russ.).
Cherniy VI, Andronova IA, Gorodnik GA, et al. Neuromediator mechanisms of restoration of consciousness in patients with severe brain injury. Emergency Medicine. 2018;1(88):114-121. (In Russ.).
Samotrueva MA. Experimental assessment of the immunotropic effect of phenotropil under conditions of blocked different types of GABA receptors. In the collection: Collection of materials of the IV All-Russian scientific and practical conference with international participation «Innovations in the health of the nation.» St. Petersburg State Chemical and Pharmaceutical Academy. 2016;524-527. (In Russ.).
Firstova YuYu, Abaimov DA, Kapitsa IG, et al. The influence of scopolamine and the nootropic drug fenotropil on neurotransmitter receptors in the brain of rats in the conditioned passive avoidance reflex test. Neurochemistry. 2011;28(2):130-141. (In Russ.).
Zvejniece L, Zvejniece B, Videja M, et al. Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice. Inflammopharmacology. 2020 Oct;28(5):1283-1292. https://doi.org/10.1007/s10787-020-00705-7
Afanasov VS, Ivashev MN, Sergienko AV. Phenotropil restores color vision. International Journal of Experiential Education. 2015;12(2):231-232. (In Russ.).
Basinsky SN, Basinsky AS. Double-blind, placebo-controlled study of phenotropil in the treatment of patients with primary unstabilized glaucoma. Scientific notes of Oryol State University. Series: Natural, technical and medical sciences. 2008;2:61-64. (In Russ.).
Firstova IuIu, Vasil’eva EV, Kovalev GI. Studying specific effects of nootropic drugs on glutamate receptors in the rat brain. Eksp Klin Farmakol. 2011;74(1):6-10.
Alekseeva LV, Gamzin SS. Activity of carboxypeptidase E in the nervous tissue of rats after a single administration of nootropic drugs. Bulletin of Tver State University. Series: Biology and ecology. 2016;2:20-29. (In Russ.).
Alekseeva LV, Gamzin SS. Activity of peptidyl dipeptidase A in the nervous tissue of rats during long-term effect of nootropic drugs. Bulletin of Tver State University. Series: Biology and ecology. 2016;1:34-42. (In Russ.).
Firstova YuYu, Dolotov OV, Kondrakhin EA, et al. Influence of nootropic drugs on the BDNF level in the hippocampus and cerebral cortex of mice with different effectiveness of exploratory behavior. Exp Clin Pharmacol. 2009;72(6):3-6. (In Russ.).
Torshin IYu, Rubashkina AN, Gromova OA. Chemotranscriptomic analysis of the effects of the 7-hydroxymatairesinol molecule on human breast tumor cells of the MCF7 line. Obstetrics, Gynecology and Reproduction. 2018;23:34-38. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.409
Kryukov VV, Krasnov VN, Ryzhova IA, et al. Assessment of the Influence of phenotropil on organic mental disorders . In the book: Modern principles of therapy and rehabilitation of mentally ill patients. Plenum of the Board of the Russian Society of Psychiatrists. 2006;45-46. (In Russ.).
Vasilyeva EV, Salimov RM, Kovalev GI. Influence of nootropic drugs on the behavior of BALB/C and C57BL/6 mice in a cross-shaped maze. Exp Clin Pharmacol. 2012;75(7):3-7. (In Russ.).
Horvat NV. Effectiveness of risperidone and phenotropil in the treatment of schizophrenia in elderly patients. Dis. … cand med sci. Kursk. 2006. (In Russ.).
Akhapkina VI, Akhapkin RV. Identification and evaluation of neuroleptic activity of phenotropil. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(7):42-46. (In Russ.).
Mikheykina OV, Okhapkin AS. Use of phenotropil in attention deficiency syndrome with hyperactivity in children of primary school age. Review of Psychiatry and Medical Psychology n.a. V.M. Bekhterev. 2009;4:58-59. (In Russ.).
Luzhnova SA, Samotrueva MA, Duiko VV, et al. Psychocorregive activity of phenotropil in dapsone-induced behavioral disorders. Basic Research. 2014;6(1):67-71. (In Russ.).
Kucheryavenko AS. Study of the effect of compounds vma 10-18 and vma 13-15 on the functional state of the endothelium in rats after chronic alcohol intoxication. In the collection: XXVI regional conference of young scientists and researchers of the Volgograd region. Digest of articles. Volgograd State Medical University. Volgograd. 2023;470-472. (In Russ.).
Borodkina LE, Smolnyakova YuA, Muzyko EA, Tyurenkov IN. Changes in the psychoemotional state under the influence of neuroaactive amino acids derivatives in rats after chronic alcohol intoxication. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(4):112-116. (In Russ.). https://doi.org/10.17116/jnevro2022122041112
Ivanets NN, Vinnikova MA, Mokhnachev SO, et al. Therapeutic effectiveness and safety of use of phenotropil in patients with alcohol dependence. Issues of Addiction. 2008;4:16-32. (In Russ.).
Kuzembaeva LB. Individual sensitivity to the effect of nootropics in patients with alcoholism in the post withdrawal period. Diss. … cand. med. sci. St. Petersburg. 2009. (In Russ.).
Barylnik YuB, Fillipova NV, Sizov SV. Studying the effectiveness and safety of phenotropil in complex therapy of alcohol dependence. Narcology. 2013;12(12):61-64. (In Russ.).
Akhapkina VI. Rejuvenation, repair and anti-creving activity of the modulating drug fenotropil. Pharmateka. 2013;6(259):130-135. (In Russ.).
Drachouv IS, Bykov VN, Seleznev AB. Administration of Palonosetron and Phenotropil for Prophylaxis of the N-V-D Stage of Acute Radiation Syndrome. Radiats Biol Radioecol. 2016 Jan-Feb;56(1):64-72.
Potievskaya VI, Potievsky BG, Chizhov AYa. Influence of the drug fenotropil on the time of adaptation to intermittent normobaric hypoxia in civil aviation pilots and persons of ground professions. Bulletin of the Peoples’ Friendship University of Russia. Series: Ecology and life safety. 2004;1:110-115. (In Russ.).
Khusainova GKh. Derivatives of neuroactive amino acids as regulators of the functional state of mitochondria in excitable tissues of rats in normal conditions and in experimental pathologies. Diss. … Cand. Pharm. Sci. Volgograd. 2022. (In Russ.).
Khusainova GKh, Popova TA, Kustova MV, Ostrovsky OV. The influence of GABA and glutamic acid derivatives on the functional activity of liver cell mitochondria in vitro under conditions of oxidative stress. Bulletin of Volgograd State Medical University. 2022;19(1):147-152. (In Russ.).
Zhiliuk VI, Mamchur VI, Pavlov SV. Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia. Eksp Klin Farmakol. 2015;78(2):10-14.
Tyurenkov IN, Samotrueva MA, Tsibizova AA, Yasenyavskaya AL. Phenotropil as a modulator of cytokine levels in experimental immunopathology. Exp Clin Pharmacol. 2015;78(12):15-17. (In Russ.).
Samotrueva MA, Magomedov MM, Khlebtsova EB, Tiurenkov IN. [Influence of GABA derivatives on some indices of lipid peroxidation in immunocompetent organs under experimental immunopathology conditions. Eksp Klin Farmakol. 2011;74(8):32-36. (In Russ.).
Troshina EA, Ershova EV. Pharmacotherapy of obesity: what’s new? Problems of Endocrinology. 2018;64(4):270-276. (In Russ.).
Zhilyuk VI, Levykh AE, Mamchur VI. A study of the mechanisms for antiaggregant activity of pyrrolidone derivatives in rats with chronic hyperglycemia. Bull Exp Biol Med. 2014 Apr;156(6):799-802. https://doi.org/10.1007/s10517-014-2454-8
Tyurenkov IN, Bakulin DA, Andriashvili TM, et al. Screening in a number of structural analogues of GABA substances with pancreoprotective effect. Medicinal Bulletin. 2023;3(91):36-42. (In Russ.).
Zvejniece L, Svalbe B, Vavers E, et al. S-phenylpiracetam, a selective DAT inhibitor, reduces body weight gain without influencing locomotor activity. Pharmacol Biochem Behav. 2017 Sep;160:21-29. https://doi.org/10.1016/j.pbb.2017.07.009

Close metadata